Have a personal or library account? Click to login

Bromelain-based chemo-herbal combination effect on human cancer cells: in-vitro study on AGS and MCF7 proliferation and apoptosis

Open Access
|Sep 2020

References

  1. 1. DeSantis CE, Lin LC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71.10.3322/caac.2123524890451
  2. 2. Raeisi E, Aghamiri SM, Bandi A, Rahmatpour N, Firoozabadi SM, Kafi-Abad SA, et al. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model. Radiol Oncol. 2012;46(3):226-32.10.2478/v10019-012-0035-x347294723077461
  3. 3. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52-79.10.1016/j.ejpb.2015.03.01825813885
  4. 4. Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.10.1016/j.bioorg.2019.10292531003078
  5. 5. Damia G, Broggini M. Platinum resistance in ovarian cancer: Role of DNA repair. Cancers (Basel). 2019;11(1):119.10.3390/cancers11010119635712730669514
  6. 6. Maehara Y, Oki E, Saeki H, Tokunaga E, Kitao H, Iimori M, et al. Evolving 5-fluorouracil therapy to achieve enhanced efficacy-past and current efforts of researchers. Gan To Kagaku Ryoho. 2016; 43(7):845-54.
  7. 7. Sun W, Sanderson P, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today. 2016;21(7): 1189-95.10.1016/j.drudis.2016.05.015490786627240777
  8. 8. Rathnavelu V, Alitheen N, Sohila S, Kanagesan S, Ramesh R. Potential role of bromelain in clinical and therapeutic applications. Biomed Rep. 2016;5(3):283-8.10.3892/br.2016.720499815627602208
  9. 9. Satari A, Amini AS, Raeisi E, Lemoigne Y, Hiedarian E. Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in pc3 cancer cells through the modulation of p53 gene expression. Adv Pharm Bull. 2019;9(3):462-9.10.15171/apb.2019.055677393931592435
  10. 10. Pauzi AZ, Yeap S, Abu N, Lim KL, Omar AR, Aziz SA, et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med. 2016;11:46.10.1186/s13020-016-0118-5511126427891174
  11. 11. Raeisi F, Shahbazi-Gahrouei D, Raeisi E, Heidarian E. Evaluation of the radiosensitizing potency of bromelain for radiation therapy of 4t1 breast cancer cells. J Med Signals Sens. 2019;9(1):68-74.10.4103/jmss.JMSS_25_18641956430967992
  12. 12. Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Bromelain and n-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: Significance of combination therapy. J Exp Clin Cancer Res. 2014;33(1):92.
  13. 13. Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Potentiation of chemotherapeutics by bromelain and n-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res. 2016;6(2):350-69.
  14. 14. Müller A, Barat S, Chen X, Bui KC, Bozko P, Malek NP, et al. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. Int J Oncol. 2016;48(5): 2025-34.10.3892/ijo.2016.341126935541
  15. 15. Pillai K, Ehteda A, Akhter J, Chua TC, Morris DL. Anticancer effect of bromelain with and without cisplatin or 5-fu on malignant peritoneal mesothelioma cells. Anticancer Drugs. 2014;25(2):150-60.10.1097/CAD.000000000000003924366282
DOI: https://doi.org/10.2478/cipms-2020-0028 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 155 - 161
Submitted on: Jun 19, 2019
Accepted on: Jul 24, 2019
Published on: Sep 13, 2020
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 Elham Raeisi, Mathias Hossain Aazami, Seyed Mahmud Reza Aghamiri, Atefeh Satari, Safoura Hosseinzadeh, Yves Lemoigne, Esfandiar Heidarian, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.